20
May 2026
Engineered nanomaterials optimize delivery barriers in cancer immunotherapy
Cancer immunotherapy works by mobilizing the body's own immune system to recognize and destroy malignant cells.
Stay Informed!
20
May 2026
Spatial modeling of tissue compartments predicts breast cancer treatment response
HER2-positive breast cancer accounts for about 20% of breast cancer cases and is generally associated with more aggressive behavior and a higher risk of distant metastasis, while pathologic complete response (pCR) after neoadjuvant chemotherapy is strongly linked to better survival outcomes.
20
May 2026
Sino Biological launches XPressMAX™ Cell-Free Protein Synthesis Kit, accelerating AI-powered high-throughput antibody drug discovery
Sino Biological, Inc., a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free Protein Synthesis Kit (Cat#: CFKIT02) , a cutting-edge solution designed to supercharge artificial intelligence (AI)-driven high-throughput screening pipelines for antibody drug discovery.
20
May 2026
Blood protein biomarkers predict psychosis risk in Asian youth
A new study by researchers from NHG Health's Institute of Mental Health (IMH) and Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine) has identified blood-based proteomic biomarkers that may help predict who among the at-risk group is at increased risk of developing psychosis.
20
May 2026
Diverse AI foundation models transform universal eye care imaging
Artificial intelligence (AI) has already changed many aspects of medical imaging, but traditional ophthalmic AI systems are often built for a single disease, dataset, or task.
20
May 2026
Aerobic exercise mitigates nanoplastic damage in female zebrafish
Using female zebrafish as a model, researchers have found that aerobic exercise may influence various connections in the body to lessen the damaging health impacts of environmental nanoplastics.
20
May 2026
Early electronic advance directives reduce burdensome end-of-life care
Advance directives document patient preferences for future care, including end-of-life. An analysis in the Journal of the American Geriatrics Society found that older patients with an advance directive that had been uploaded into the electronic health record at least six months before death were 25% less likely to experience potentially burdensome end-of-life care (19.9% versus 26.8%) and 31% less likely to have died in the hospital (23.2% versus 32.1%).
20
May 2026
Vitamin C may reduce cancer-linked digestive chemical reactions
A new study from the University of Waterloo uses mathematical modeling to examine how Vitamin C affects chemical reactions in the digestive system that are linked to cancer development.
20
May 2026
Bedfont® Scientific targets international growth at EAACI Congress 2026
Bedfont® Scientific Ltd., an innovative leader in the medical breath analysis industry with almost 50 years of experience, is pleased to join thousands of healthcare experts at this year’s European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026 at stand I03 to showcase its NObreath® and Gastrolyzer® range of non-invasive breath analysis devices.
20
May 2026
Researchers uncover new genetic links influencing blood lipid composition
DZNE researchers have generated new insights into how the human genome shapes the chemical composition and concentration of blood lipids.
